Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Aug-22 4:02 PM View:  | Tang Kevin C Director 10% Owner | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition (change in control) Duplicate | 9,607,930 | $6.23 | $59,857,400.00 | (100%) 9.61M to 0 | |
| 24-Aug-22 8:17 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition | 10,186 | $6.23 | $63,458.80 | (< 1%) 9.62M to 9.61M | |
| 24-Aug-22 8:21 PM View: | Tang Kevin C Director 10% Owner | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition (change in control) Duplicate | 9,607,930 | $6.23 | $59,857,400.00 | (100%) 9.61M to 0 | |
| 24-Aug-22 8:18 PM View: | Douglass Laura L. Director | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition | 500 | $6.23 | $3,115.00 | (100%) 0.5K to 0 | |
| 24-Aug-22 8:22 PM View: | Ramsay David A Director | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition | 100,000 | $6.23 | $623,000.00 | (100%) 100.0K to 0 | |
| 24-Aug-22 8:20 PM View: | Edwards Larry G. Chief Executive Officer Director | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition | 11,969 | $6.23 | $74,566.90 | (100%) 11.97K to 0 | |
| 24-Aug-22 8:17 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition (change in control) | 9,607,930 | $6.23 | $59,857,400.00 | (100%) 9.61M to 0 | |
| 24-Aug-22 8:17 PM View: | Johnson Craig A Director | La Jolla Pharmaceutical Co. (LJPC) | 22-Aug-22 | Disposition | 12,000 | $6.23 | $74,760.00 | (100%) 12.0K to 0 | |
| 12-Jul-22 8:36 PM View: | Johnson Craig A Director | La Jolla Pharmaceutical Co. (LJPC) | 08-Jul-22 | Option Exercise | 12,000 | $3.93 | $47,160.00 | 100% 0 to 12.0K | |
| 05-Jul-22 5:51 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Jun-22 | Grant | 236 | $2.71 | $639.91 | < 1% 9.62M to 9.62M | |
| 17-Jun-22 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Jun-22 | Grant | 236 | $2.72 | $641.92 | < 1% 9.62M to 9.62M | |
| 02-Jun-22 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 31-May-22 | Grant | 189 | $3.41 | $644.21 | < 1% 9.62M to 9.62M | |
| 17-May-22 5:07 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 13-May-22 | Grant | 188 | $3.41 | $640.80 | < 1% 9.62M to 9.62M | |
| 03-May-22 5:00 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 29-Apr-22 | Grant | 185 | $3.47 | $641.58 | < 1% 9.62M to 9.62M | |
| 18-Apr-22 6:31 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 14-Apr-22 | Grant | 173 | $3.71 | $642.61 | < 1% 9.62M to 9.62M | |
| 18-Apr-22 6:32 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 14-Apr-22 | Grant | 296 | $3.71 | $1,099.49 | 3% 11.67K to 11.97K | |
| 04-Apr-22 5:39 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 31-Mar-22 | Grant | 334 | $3.63 | $1,212.25 | 3% 11.34K to 11.67K | |
| 04-Apr-22 5:38 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 31-Mar-22 | Grant | 177 | $3.63 | $642.42 | < 1% 9.62M to 9.62M | |
| 17-Mar-22 9:06 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Mar-22 | Grant | 361 | $3.37 | $1,215.13 | 3% 10.98K to 11.34K | |
| 17-Mar-22 9:04 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Mar-22 | Grant | 190 | $3.37 | $639.54 | < 1% 9.62M to 9.62M | |
| 02-Mar-22 5:07 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 28-Feb-22 | Grant | 185 | $3.48 | $643.15 | < 1% 9.62M to 9.62M | |
| 02-Mar-22 5:08 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 28-Feb-22 | Grant | 350 | $3.48 | $1,216.78 | 3% 10.63K to 10.98K | |
| 17-Feb-22 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Feb-22 | Grant | 169 | $3.79 | $640.68 | < 1% 9.62M to 9.62M | |
| 17-Feb-22 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Feb-22 | Grant | 320 | $3.79 | $1,213.12 | 3% 10.31K to 10.63K | |
| 02-Feb-22 7:19 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 31-Jan-22 | Grant | 1,675 | $3.94 | $6,591.96 | < 1% 9.61M to 9.62M | |
| 02-Feb-22 7:21 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 31-Jan-22 | Grant | 4,170 | $3.94 | $16,411.00 | 68% 6.14K to 10.31K | |
| 19-Jan-22 8:26 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 14-Jan-22 | Grant | 148 | $4.18 | $618.94 | < 1% 9.61M to 9.61M | 7% |
| 19-Jan-22 8:27 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 14-Jan-22 | Grant | 273 | $4.18 | $1,141.69 | 5% 5.87K to 6.14K | 7% |
| 04-Jan-22 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Dec-21 | Grant | 157 | $3.92 | $615.20 | < 1% 9.61M to 9.61M | |
| 04-Jan-22 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Dec-21 | Grant | 233 | $3.92 | $913.01 | 4% 5.63K to 5.87K | |
| 17-Dec-21 5:58 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Dec-21 | Grant | 173 | $3.58 | $619.08 | < 1% 9.61M to 9.61M | |
| 17-Dec-21 6:01 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Dec-21 | Grant | 320 | $3.58 | $1,145.12 | 6% 5.31K to 5.63K | |
| 06-Dec-21 9:01 PM View: | Ramsay David A Director | La Jolla Pharmaceutical Co. (LJPC) | 06-Dec-21 | Market Purchase | 10,000 | $3.82 | $38,230.80 | 11% 90.0K to 100.0K | < 1% |
| 06-Dec-21 9:01 PM View: | Ramsay David A Director | La Jolla Pharmaceutical Co. (LJPC) | 03-Dec-21 | Market Purchase | 4,399 | $3.66 | $16,082.40 | 5% 85.6K to 90.0K | 5% |
| 06-Dec-21 9:01 PM View: | Ramsay David A Director | La Jolla Pharmaceutical Co. (LJPC) | 02-Dec-21 | Market Purchase | 10,101 | $3.73 | $37,676.70 | 13% 75.5K to 85.6K | 3% |
| 01-Dec-21 7:07 PM View: | Tang Kevin C Director 10% Owner | La Jolla Pharmaceutical Co. (LJPC) | 01-Dec-21 | Market Sale | 177,545 | $3.74 | $663,431.00 | (2%) 9.79M to 9.61M | (2%) |
| 02-Dec-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Nov-21 | Grant | 186 | $3.32 | $616.59 | < 1% 10.06M to 10.06M | |
| 02-Dec-21 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Nov-21 | Grant | 346 | $3.32 | $1,146.99 | 7% 4.97K to 5.31K | |
| 01-Dec-21 7:07 PM View: | Tang Kevin C Director 10% Owner | La Jolla Pharmaceutical Co. (LJPC) | 30-Nov-21 | Market Sale | 70,342 | $3.95 | $277,612.00 | (< 1%) 9.86M to 9.79M | 3% |
| 01-Dec-21 7:07 PM View: | Tang Kevin C Director 10% Owner | La Jolla Pharmaceutical Co. (LJPC) | 29-Nov-21 | Market Sale | 193,403 | $4.10 | $793,107.00 | (2%) 10.05M to 9.86M | 7% |
| 19-Nov-21 5:05 PM View: | Ramsay David A Director | La Jolla Pharmaceutical Co. (LJPC) | 17-Nov-21 | Market Purchase | 7,500 | $4.23 | $31,725.00 | 11% 68.0K to 75.5K | (9%) |
| 17-Nov-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Nov-21 | Grant | 181 | $3.41 | $616.94 | < 1% 10.05M to 10.06M | |
| 17-Nov-21 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Nov-21 | Grant | 336 | $3.41 | $1,145.26 | 7% 4.63K to 4.97K | |
| 02-Nov-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 29-Oct-21 | Grant | 181 | $3.42 | $618.48 | < 1% 10.05M to 10.05M | |
| 02-Nov-21 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 29-Oct-21 | Grant | 335 | $3.42 | $1,144.70 | 8% 4.29K to 4.63K | |
| 19-Oct-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Oct-21 | Grant | 183 | $3.37 | $615.98 | < 1% 10.05M to 10.05M | |
| 19-Oct-21 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Oct-21 | Grant | 341 | $3.37 | $1,147.81 | 9% 3.95K to 4.29K | |
| 04-Oct-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Sep-21 | Grant | 182 | $3.39 | $617.25 | < 1% 10.05M to 10.05M | |
| 04-Oct-21 5:10 PM View: | Edwards Larry G. Chief Executive Officer | La Jolla Pharmaceutical Co. (LJPC) | 30-Sep-21 | Grant | 338 | $3.39 | $1,146.33 | 9% 3.62K to 3.95K | |
| 17-Sep-21 5:05 PM View: | Hearne Michael S Chief Financial Officer | La Jolla Pharmaceutical Co. (LJPC) | 15-Sep-21 | Grant | 546 | $3.39 | $1,851.76 | < 1% 10.05M to 10.05M |
